Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT
Gleixner, Karoline V, Mayerhofer, Matthias, Sonneck, Karoline, Gruze, Alexander, Samorapoompichit, Puchit, Baumgartner, Christian, Lee, Francis Y, Aichberger, Karl J, Manley, Paul W, Fabbro, Doriano, Pickl, Winfried F, Sillaber, Christian, Valent, Peter
Published in Haematologica (Roma) (01.11.2007)
Published in Haematologica (Roma) (01.11.2007)
Get full text
Journal Article
Evaluation of antileukaemic effects of rapamycin in patients with imatinib-resistant chronic myeloid leukaemia
Sillaber, C., Mayerhofer, M., Böhm, A., Vales, A., Gruze, A., Aichberger, K. J., Esterbauer, H., Pfeilstöcker, M., Sperr, W. R., Pickl, W. F., Haas, O. A., Valent, P.
Published in European journal of clinical investigation (01.01.2008)
Published in European journal of clinical investigation (01.01.2008)
Get full text
Journal Article
Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy
Gleixner, K V, Mayerhofer, M, Vales, A, Gruze, A, Hörmann, G, Cerny-Reiterer, S, Lackner, E, Hadzijusufovic, E, Herrmann, H, Iyer, A K, Krauth, M-T, Pickl, W F, Marian, B, Panzer-Grümayer, R, Sillaber, C, Maeda, H, Zielinski, C, Valent, P
Published in Current cancer drug targets (01.08.2009)
Published in Current cancer drug targets (01.08.2009)
Get more information
Journal Article
PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects
Gleixner, Karoline V., Mayerhofer, Matthias, Aichberger, Karl J., Derdak, Sophia, Sonneck, Karoline, Böhm, Alexandra, Gruze, Alexander, Samorapoompichit, Puchit, Manley, Paul W., Fabbro, Doriano, Pickl, Winfried F., Sillaber, Christian, Valent, Peter
Published in Blood (15.01.2006)
Published in Blood (15.01.2006)
Get full text
Journal Article
Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutation
Hadzijusufovic, Emir, Peter, Barbara, Rebuzzi, Laura, Baumgartner, Christian, Gleixner, Karoline V., Gruze, Alexander, Thaiwong, Tuddow, Pickl, Winfried F., Yuzbasiyan-Gurkan, Vilma, Willmann, Michael, Valent, Peter
Published in Veterinary immunology and immunopathology (15.12.2009)
Published in Veterinary immunology and immunopathology (15.12.2009)
Get full text
Journal Article
Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells
Rebuzzi, Laura, Willmann, Michael, Sonneck, Karoline, Gleixner, Karoline V., Florian, Stefan, Kondo, Rudin, Mayerhofer, Matthias, Vales, Anja, Gruze, Alexander, Pickl, Winfried F., Thalhammer, Johann G., Valent, Peter
Published in Veterinary Immunology and Immunopathology (15.02.2007)
Published in Veterinary Immunology and Immunopathology (15.02.2007)
Get full text
Journal Article
The Hsp32/HO-1-targeted drug SMA-ZnPP counteracts the proliferation and viability of neoplastic cells in solid tumors and hematologic neoplasms
Gleixner, K. V., Mayerhofer, M., Vales, A., Gruze, A., Pickl, W. F., Lackner, E., Sillaber, C., Zielinski, C. C., Maeda, H., Valent, P.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Abstracts presented at the ESVONC autumn meeting, Budapest, Hungary, 13-15 September 2007
Published in Veterinary & comparative oncology
(01.03.2008)
Get full text
Journal Article